These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 11244047)

  • 1. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.
    Chambers CA; Kuhns MS; Egen JG; Allison JP
    Annu Rev Immunol; 2001; 19():565-94. PubMed ID: 11244047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA-4: new insights into its biological function and use in tumor immunotherapy.
    Egen JG; Kuhns MS; Allison JP
    Nat Immunol; 2002 Jul; 3(7):611-8. PubMed ID: 12087419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
    Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
    J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
    Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
    J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.
    Metz DP; Farber DL; Taylor T; Bottomly K
    J Immunol; 1998 Dec; 161(11):5855-61. PubMed ID: 9834064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulation and its role in organ transplantation.
    Bluestone JA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
    Eagar TN; Karandikar NJ; Bluestone JA; Miller SD
    Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis.
    Perrin PJ; Scott D; Quigley L; Albert PS; Feder O; Gray GS; Abe R; June CH; Racke MK
    J Immunol; 1995 Feb; 154(3):1481-90. PubMed ID: 7529805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function.
    Coyle AJ; Gutierrez-Ramos JC
    Nat Immunol; 2001 Mar; 2(3):203-9. PubMed ID: 11224518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.
    Davila E; Kennedy R; Celis E
    Cancer Res; 2003 Jun; 63(12):3281-8. PubMed ID: 12810660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.
    Sperling AI; Auger JA; Ehst BD; Rulifson IC; Thompson CB; Bluestone JA
    J Immunol; 1996 Nov; 157(9):3909-17. PubMed ID: 8892622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell regulation by CD28 and CTLA-4.
    Alegre ML; Frauwirth KA; Thompson CB
    Nat Rev Immunol; 2001 Dec; 1(3):220-8. PubMed ID: 11905831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability.
    Finn PW; He H; Wang Y; Wang Z; Guan G; Listman J; Perkins DL
    J Immunol; 1997 May; 158(9):4074-81. PubMed ID: 9126965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
    Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW
    J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.